Neoadjuvant Darolutamide Alone or in Combination With Standard Therapy for Stage II-IIIA, AR+, TNBC
Vanderbilt-Ingram Cancer Center
Vanderbilt-Ingram Cancer Center
CellCentric Ltd.
OHSU Knight Cancer Institute
University Health Network, Toronto
UNICANCER